Literature DB >> 11532514

Myelodysplasia with fibrosis: a distinct entity?

D P Steensma1, C A Hanson, L Letendre, A Tefferi.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11532514     DOI： 10.1016/s0145-2126(01)00055-8

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  6 in total

1.  Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.

Authors:  Nicolaus Kröger; Tatjana Zabelina; Anja van Biezen; Ronald Brand; Dietger Niederwieser; Rodrigo Martino; Zi Yi Lim; Francesco Onida; Christoph Schmid; Laurent Garderet; Marie Robin; Michael van Gelder; Reinhard Marks; Argiris Symeonidis; Guido Kobbe; Theo de Witte
Journal:  Haematologica       Date:  2010-10-22       Impact factor: 9.941

2.  Myelodysplastic syndrome with myelofibrosis transformed to a precursor B-cell acute lymphoblastic leukemia: a case report with review of the literature.

Authors:  Ayed A Algarni; Mojtaba Akhtari; Kai Fu
Journal:  Case Rep Hematol       Date:  2012-03-29

3.  Acute panmyelosis with myelofibrosis - a rare subtype of acute myeloid leukemia.

Authors:  Tathagata Chatterjee; Srishti Gupta; Ajay Sharma; Sanjeevan Sharma; Devika Gupta
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-06-04       Impact factor: 2.576

4.  Myelodysplastic syndromes/neoplasms: recent classification system based on World Health Organization Classification of Tumors - International Agency for Research on Cancer for Hematopoietic and Lymphoid Tissues.

Authors:  Geetanjali Gupta; Reecha Singh; Dhananjay S Kotasthane; Vaishali D Kotasthane
Journal:  J Blood Med       Date:  2010-08-25

Review 5.  Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update.

Authors:  Akriti G Jain; Ling Zhang; John M Bennett; Rami Komrokji
Journal:  Ann Lab Med       Date:  2022-05-01       Impact factor: 3.464

Review 6.  Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes.

Authors:  Hussein Awada; Carmelo Gurnari; Arda Durmaz; Hassan Awada; Simona Pagliuca; Valeria Visconte
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.